SEC Filing Summary: AVROBIO, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by AVROBIO, Inc. (not Tectonic Therapeutic, Inc.) on June 10, 2022, covering events occurring on June 8, 2022. The filing details the results of the Company's 2022 Annual Meeting of Stockholders held in Cambridge, MA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Stockholders voted on three primary proposals at the Annual Meeting:
- Director Elections: Stockholders elected three Class I directors (Gail Farfel, Ph.D., Christopher Paige, Ph.D., and Philip Vickers, Ph.D.) to serve until the 2025 annual meeting. All three nominees received significant support, with votes "For" ranging from approximately 20.1 million to 20.7 million.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022. The proposal passed with 33,776,363 votes "For" versus 57,906 votes "Against."
- Compensation Plan Amendment: Stockholders approved an amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan. The proposal received 19,689,955 votes "For" and 6,688,108 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on business outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the submission of matters to a vote of security holders.
Key Facts for Investor Verification
- Verify the specific terms of the "Second Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan" referenced in Exhibit 10.1.
- Confirm the tenure and background of the newly elected Class I directors (Farfel, Paige, Vickers) serving until 2025.
- Note the significant number of broker non-votes (7,438,917) recorded for the director elections and the stock plan amendment.
- Review the Company's most recent 10-K or 10-Q for financial data, as this 8-K contains no financial metrics.